Sandford Schocket, MD
Pain Medicine · Austin, TXNPI 1851381818
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (57.9%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 34 manufacturers reported payments, led by Abbott at 37.6% of the total. Reporting peaked in 2019 at $8,919 and has fallen 81.8% since, to $1,621 in 2025.
Across 368 payments — averaging $59.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$8K
- Stimwave Technologies Incorporated$7K
- Medtronic$1K
- SPR Therapeutics, Inc$1K
- Boston Scientific$962
- Spinal Simplicity, LLC$653
- plus $2K from 28 others
Across 3 payments — averaging $2175.07 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- GRT US Holding, Inc.$7K
What the payments were for
- Consulting fees$2,61312%
- Travel & lodging$5,12024%
- Food & beverage$12,58258%
- Gifts$2341%
- Entertainment$1,1945%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 198 | $8,172 |
| Stimwave Technologies Incorporated | 23 | $7,029 |
| Medtronic(2 entities) | 24 | $1,377 |
| SPR Therapeutics, Inc | 4 | $1,074 |
| Boston Scientific | 25 | $962 |
| Spinal Simplicity, LLC | 11 | $653 |
| Relievant Medsystems, Inc. | 6 | $364 |
| Nevro Corp. | 13 | $292 |
| AbbVie(2 entities) | 14 | $289 |
| Foundation Fusion Solutions, LLC | 3 | $238 |
| Globus Medical | 3 | $215 |
| Curonix LLC | 1 | $165 |
| Vertiflex, Inc. | 2 | $130 |
| Pfizer | 7 | $126 |
| Si-bone, Inc. | 3 | $84 |
| Collegium Pharmaceutical, Inc. | 5 | $81 |
| Amgen(2 entities) | 3 | $58 |
| Johnson & Johnson Surgical Vision, Inc. | 1 | $46 |
| Novartis | 3 | $45 |
| Arbor Pharmaceuticals, Inc. | 2 | $41 |
| Nalu Medical, Inc. | 2 | $40 |
| Scilex Pharmaceuticals Inc. | 2 | $32 |
| Convatec Inc. | 2 | $32 |
| Tersera Therapeutics LLC | 1 | $30 |
| Pacira Pharmaceuticals Incorporated | 1 | $24 |
| Johnson & Johnson | 1 | $20 |
| GRT US Holding, Inc. | 1 | $20 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $20 |
| AstraZeneca | 1 | $16 |
| Daiichi Sankyo Inc. | 1 | $15 |
| Shionogi Inc | 1 | $14 |
| Teva Pharmaceuticals USA, Inc. | 1 | $12 |
| Vertical Pharmaceuticals, LLC | 1 | $12 |
| Forte Bio-pharma LLC | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Neuromodulation Dspsbls and Accs$2,613
- PROCLAIM$1,489
- SPRINT PNS System$1,065
- Proclaim IPG$631
- VANTA ADAPTIVESTIM$520
- Proclaim Family of SCS IPGs$465
- GENERAL PAIN MANAGEMENT$441
- HA MINUTEMAN G3-R$404
- Intracept$300
- INTELLIS ADAPTIVESTIM$299
- Senza$172
- PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A$165
- GENERAL - THERAPIES$143
- Superion ISS$111
How this compares
$21,742 in reported general payments places this provider in the 85th percentile of 583 pain medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 1,530 | $48,888 |
| BelbucaBuprenorphine Hcl | 61 | $36,361 |
| NucyntaTapentadol Hcl | 20 | $23,718 |
| Nucynta ErTapentadol Hcl | 23 | $22,989 |
| Hydrocodone Bitartrate ErHydrocodone Bitartrate | 24 | $10,637 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 349 | $10,253 |
| Pregabalin | 528 | $10,240 |
| Buprenorphine | 29 | $7,353 |
| Xtampza ErOxycodone Myristate | 24 | $7,312 |
| Morphine Sulfate ErMorphine Sulfate | 308 | $7,080 |
| LyricaPregabalin | 11 | $6,017 |
| Pregabalin ErPregabalin | 11 | $4,456 |
| ButransBuprenorphine | 13 | $4,419 |
| Hysingla ErHydrocodone Bitartrate | 12 | $4,104 |
| Oxycodone Hcl | 203 | $3,191 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Belbuca, Nucynta, Nucynta Er, Xtampza Er | $81 | $90,380128 claims |
| PfizerLyrica | $126 | $6,01711 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 583 pain medicine providers in Texas.
Other pain medicine in Austin
- Raj PatelAustin$120K
- Ramesh SingaAustin$34K
- Robert MousselliAustin$34K
- Mahan OstadianAustin$27K
- Raimy AmashaAustin$26K
- Matthew McCartyAustin$26K
- Sauman RafiiAustin$24K
- Melissa MurphyGrapevine$653K
- Shiraz YazdaniLubbock$514K
- Aaron CalodneyTyler$296K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.